Last reviewed · How we verify
NCT03864484
iPad Application-based Intervention for Post-stroke Depression
NA trial testing iPad Application + Usual Rehabilitation in Post-stroke Depression in 32 participants. Status unknown.
30 March 2022
Quick facts
| Lead sponsor | Kibi International University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 32 |
| Start date | 7 May 2019 |
| Primary completion | 30 March 2022 |
| Estimated completion | 30 March 2022 |
| Sites | 1 location across Japan |
Drugs / interventions tested
- iPad Application + Usual Rehabilitation
- Usual rehabilitation
Conditions studied
- Post-stroke Depression — all drugs for Post-stroke Depression →
Sponsor
Kibi International University
Who can join
40 and older, any sex, with Post-stroke Depression. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
We plan to conduct a randomized controlled trial to examine whether usual rehabilitation plus an iPad application-based intervention improves post-stroke depression symptoms compared to usual rehabilitation alone. The purpose of this pilot randomized controlled trial is to investigate the feasibility of the final randomized controlled trial.
Publications & conference data
4 peer-reviewed publications reference this trial (live from Europe PMC):
-
Pharmacological, non-invasive brain stimulation and psychological interventions, and their combination, for treating depression after stroke.
Allida SM, Hsieh CF, Cox KL, Patel K, et al · · 2023 · cited 11× · PMID 37417452 · DOI 10.1002/14651858.cd003437.pub5 -
An iPad application-based intervention for improving post-stroke depression symptoms in a convalescent rehabilitation ward: A pilot randomized controlled clinical trial protocol.
Uchida H, Hiragaki Y, Nishi Y, Nakahara S, et al · · 2020 · cited 8× · PMID 32944505 · DOI 10.1016/j.invent.2020.100340 -
Effects of Smartphone-Delivered Positive-Word Stimulation on Depressed Mood in People with Subthreshold Depression: Protocol for a Pilot Randomized Controlled Trial.
Ejiri H, Uchida H, Tsuchiya K, Fujiwara K, et al · · 2021 · cited 3× · PMID 34456565 · DOI 10.2147/ndt.s323126 -
Erratum: Effects of Smartphone-Delivered Positive-Word Stimulation on Depressed Mood in People with Subthreshold Depression: Protocol for a Pilot Randomized Controlled Trial [Corrigendum].
· 2021 · PMID 34511915 · DOI 10.2147/ndt.s336378
Verify or expand the search:
- PubMed search for NCT03864484
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Post-stroke Depression
Currently open trials in the same condition.
- NCT07294274 — Construction and Clinical Validation Study of a Prediction Model for Depression After Ischemic Stroke · recruiting
- NCT06598670 — Transcranial Direct Current Stimulation on Post Stroke Depression · NA · recruiting
Other Kibi International University trials
Trials by the same sponsor.
- NCT04136041 — Study Protocol for a Smartphone Application-based Intervention for Subthreshold Depression · NA · completed
- NCT03546218 — Effect of Positive-word Stimuli on the Limits of Stability During Multi-direction Reach Operation in Standing Position · NA · completed
- NCT03110016 — Smartphone Intervention for Subthreshold Depression · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03864484 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Kibi International University
- Last refreshed: 2 September 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03864484.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing